GlassScriptPhysician profile
Lekshmi Nair
NPI 1639559511
$1,311.56
in general payments reported to CMS, 2019-2025
21 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $116 · 2023: $21.23 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.51 | 2025 | Evenity, Tepezza |
| Madrigal Pharmaceuticals | $123.36 | 2025 | Rezdiffra |
| Medtronic, INC. | $122.73 | 2025 | Minimed 780g |
| Boston Scientific Corporation | $116.37 | 2020 | |
| Neurocrine Biosciences, INC. | $109.15 | 2025 | |
| Insulet Corporation | $75.24 | 2025 | Omnipod |
| Dexcom, INC. | $71.69 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $70.15 | 2025 | Ozempic |
| Amneal Pharmaceuticals LLC | $47.91 | 2025 | Unithroid |
| Beta Bionics, INC. | $46.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $43.63 | 2025 | Korlym |
| Exact Sciences Corporation | $39.60 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $34.83 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $29.13 | 2025 | |
| Ascendis Pharma Endocrinology INC | $29.13 | 2025 | Yorvipath |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $26.00 | 2025 | Cequr Simplicity |
| Chiesi USA, INC. | $25.01 | 2025 | Mycapssa |
| Abbott Laboratories | $23.53 | 2025 | Freestyle Libre 3 |
| Amphastar Pharmaceuticals, INC. | $21.77 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.23 | 2023 | Xarelto |
| Lilly USA, LLC | $16.70 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lekshmi Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.